The DEA Showed Up.
A confidential outpatient surgical facility hired a drug diversion consultant roughly a year before federal investigators came knocking. What happened next is a case study every hospital administrator needs to read.
Drug Diversion Consulting · Case Study
They Were Ready.
Here's Why.
Final DEA Determination
No Findings of Culpability
The facility proactively assessed, documented, and corrected their controlled substance systems — before investigators arrived.
The difference that mattered
A comprehensive drug diversion risk assessment conducted ~12 months prior.
Drug Diversion Consultant
By Rxpert Solutions · Case Study
How One Outpatient Surgical Facility Survived a DEA Investigation — and Why Their Drug Diversion Consultant Made All the Difference
When federal agents opened an investigation into suspected medication diversion at a confidential outpatient surgical facility, most facilities would have been caught off guard. This one wasn't. Twelve months earlier, they had made a decision that would change everything.
Nobody expects the DEA to show up. That's exactly the problem.
Drug diversion — the theft or misuse of controlled substances within a healthcare setting — is one of the most serious compliance risks facing hospitals and ambulatory surgical centers today. It compromises patient safety, exposes staff to criminal liability, and can trigger federal investigations that threaten an organization's very ability to operate. Yet most facilities only think seriously about drug diversion consulting after something has already gone wrong.
The case we're about to walk you through is different. It's the story of a facility that thought ahead — and the moment that decision paid off in ways they couldn't have anticipated.
Ambulatory surgical centers face a unique set of drug diversion challenges. Unlike large hospital systems with dedicated pharmacy oversight teams, ASCs often operate with lean staff, multiple rotating providers, and complex inventory demands across high-volume procedure days. Controlled substances flow in and out quickly — and the gaps between documented activity and actual usage can be surprisingly difficult to track.
The facility in this case was no different. Like many outpatient surgical facilities, they had multiple providers with varying prescribing patterns, complex inventory tracking requirements, and diverse staff handling controlled substances under evolving regulatory standards. Nothing was catastrophically wrong — but nothing had been independently stress-tested, either.
A High-Risk Environment Hiding in Plain Sight
The core vulnerability of most facilities isn't malicious intent — it's the absence of objective, external scrutiny. Internal teams are too close to see what outside experts spot immediately.
That's why they brought in Rxpert Solutions for a comprehensive controlled substance risk assessment — not because they had a problem, but because they understood that waiting to find one is the most expensive strategy of all.
When most people picture drug diversion consulting, they imagine a team arriving to investigate after something has gone wrong. In reality, the most valuable work our consultants do is the opposite: a structured, systematic evaluation of your controlled substance environment before any incident forces the issue.
For this facility, Rxpert Solutions conducted a thorough evaluation spanning every dimension of their controlled substance management:
We examined medication procurement and inventory systems — tracing how controlled substances entered the facility and how discrepancies were flagged and resolved. We reviewed storage and security protocols, assessing physical controls, access records, and waste procedures. We scrutinized dispensing and administration procedures, looking for the workflow gaps where diversion most commonly occurs.
Equally important: we assessed their documentation and record-keeping practices. In a DEA investigation, documentation isn't just good practice — it's evidence. Gaps in records don't just suggest poor systems; they can imply involvement. Facilities with clean, comprehensive audit trails are in an entirely different position than those with inconsistencies, regardless of what actually happened.
What Drug Diversion Consulting Actually Looks Like
Facilities that document everything — consistently, comprehensively, proactively — are in an entirely different legal and regulatory position when investigators arrive.
— Rxpert Solutions, Drug Diversion Consulting Team
The assessment also evaluated staff training and oversight mechanisms and the facility's full regulatory compliance framework. Every finding was prioritized. Every recommendation was actionable. And critically, leadership didn't just receive a report — they acted on it.
Following the Rxpert Solutions assessment, the facility's leadership committed to implementing the recommended changes — strengthening policies, enhancing security, reinforcing documentation protocols, and providing additional staff training. These weren't glamorous initiatives. They were exactly the kind of systematic, unglamorous improvements that determine whether a facility holds up under scrutiny.
Approximately twelve months later, the DEA initiated an investigation into suspected medication diversion involving a provider who held privileges at multiple facilities — including this one. The investigation was serious. The stakes were severe: loss of DEA registration, significant financial penalties, reputational damage, operational disruption.
What the investigators found, however, was very different from what they may have expected.
The Year That Changed Everything
After thorough investigation, the DEA determined that this facility had no involvement in the suspected diversion activities. No evidence linked them to any improper medication supply or diversion related to the provider in question.
The outcome — no findings of culpability — didn't happen by accident. It happened because of robust policies and procedures implemented post-assessment, strong documentation and audit trails, effective security measures, clear accountability structures, and comprehensive staff training. Every single one of those factors traces directly back to the work done with Rxpert Solutions the year before.
1
STEP 1 - PROACTIVE DECISION
Drug Diversion Risk Assessment Commissioned
Leadership engaged Rxpert Solutions for a comprehensive controlled substance risk assessment — not in response to any incident, but as a proactive compliance investment.
2
STEP 2 - ASSESSMENT DELIVERED
Vulnerabilities Identified & Prioritized
Rxpert consultants delivered findings across procurement, storage, dispensing, documentation, training, and regulatory compliance — with clear, prioritized recommendations.
The facility strengthened policies, enhanced security, reinforced documentation protocols, and invested in additional staff training across all departments involved in controlled substance management.
Leadership Acts on Every Major Finding
STEP 3 - COMMITTED IMPLEMENTATION
3
Federal investigators initiated an inquiry into suspected diversion by a provider with privileges at multiple facilities — including this one. The stakes: potential loss of DEA registration, financial penalties, and permanent reputational damage.
DEA Investigation Opens
~12 MONTHS LATER — THE CRITICAL MOMENT
4
Thorough investigation found no evidence linking the facility to any improper medication supply or diversion activities. Clean documentation, strong controls, and a well-trained staff told the real story.
DEA Clears the Facility Completely
FINAL OUTCOME — NO FINDINGS OF CULPABILITY
✓
WHAT HAPPENED & WHEN
The 5 Steps That Protected This Facility
WHAT'S AT RISK
What a DEA Investigation Can Cost Your Facility
Loss of DEA Registration
Without DEA registration, your facility cannot dispense, administer, or prescribe controlled substances — effectively ending surgical operations.
Significant Financial Penalties
Civil and criminal penalties in diversion cases can reach millions of dollars — far exceeding the cost of prevention.
Reputational Damage
DEA investigations are rarely private. The damage to patient trust and community standing can outlast the legal process by years.
0
Findings of culpability after proactive Rxpert assessment and DEA investigation
6
Core areas evaluated in every controlled substance risk assessment
1 yr
The gap between a proactive assessment and a DEA investigation — time well spent
WHAT RXPERT DRUG DIVERSION CONSULTANTS PROVIDE
Hospital Drug Diversion Consulting Services
01
Controlled Substance Risk
Assessment
A comprehensive, facility-wide evaluation of your procurement, storage, dispensing, documentation, and compliance systems — identifying vulnerabilities before they become liabilities.
02
Diversion Prevention Program Development
We design and implement robust diversion mitigation programs tailored to your facility type — from large hospital systems to ambulatory surgical centers.
03
Compliance Audits & Ongoing Monitoring
Regular audits and surveillance monitoring to ensure your controlled substance controls remain effective and audit-ready — not just on assessment day, but every day.
04
Staff Training & Education
Targeted education for clinical staff, pharmacy teams, and compliance personnel on diversion recognition, reporting procedures, and best practices.
05
Policy & Procedure Development
Regular audits and surveillance monitoring to ensure your controlled substance controls remain effective and audit-ready — not just on assessment day, but every day.
06
Subject Matter Expertise & Ongoing Advisory
Keep our drug diversion consultants in your corner as a trusted resource on retainer — available for guidance, program questions, emerging compliance needs, and expert advice whenever your team needs it.
TAKE ACTION BEFORE IT'S TOO LATE
Don't Wait for a DEA Knock to Find Out Where You Stand
The facility in this case study had roughly one year between their proactive risk assessment and the DEA investigation. That year made all the difference. Your window may be shorter.
Confidential Consultation
Healthcare-Specific Expertise
Hospitals, ASCs & Nursing Facilities Served Nationwide
DEA Investigation Experience
© 2026 Rxpert Solutions · Drug Diversion Consultants · rxpert.solutions